Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: The Generation R study

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 2, 2013, Pages 121.e1-121.e11

  Bouwland Both, Marieke I ^a   Steegers, Eric A P ^a   Lindemans, Jan ^a   Russcher, Henk ^a   Hofman, Albert ^a   Geurts Moespot, Anneke J ^b   Sweep, Fred C G J ^b   Jaddoe, Vincent W V ^a   Steegers Theunissen, Régine P M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cohort study; early fetal size; folate; placental development; placental growth factor; plasminogen activator inhibitor 2; soluble fms like tyrosine kinase 1

Indexed keywords

FOLIC ACID; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; ETHNICITY; FEMALE; FETUS; FETUS WEIGHT; GESTATIONAL AGE; HUMAN; MALE; MATERNAL AGE; NETHERLANDS; PARITY; PREGNANT WOMAN; PRIORITY JOURNAL; VENOUS BLOOD;

EID: 84880918354     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.04.009     Document Type: Article

References (44)

1. D.S. Charnock-Jones, P. Kaufmann, and T.M. Mayhew Aspects of human fetoplacental vasculogenesis and angiogenesis, I: molecular regulation Placenta 25 2004 103 113
2. E.A.P. Steegers, P. von Dadelszen, J.J. Duvekot, and R. Pijnenborg Pre-eclampsia Lancet 376 2010 631 644
3. P. Kaufmann, T.M. Mayhew, and D.S. Charnock-Jones Aspects of human fetoplacental vasculogenesis and angiogenesis, II: changes during normal pregnancy Placenta 25 2004 114 126
4. G. Makrydimas, A. Sotiriadis, M.D. Savvidou, K. Spencer, and K.H. Nicolaides Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy Prenat Diagn 28 2008 175 179
5. D.E. Clark, S.K. Smith, and Y. He A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation Biol Reprod 59 1998 1540 1548
6. G.J. Burton, E. Jauniaux, and D.S. Charnock-Jones The influence of the intrauterine environment on human placental development Int J Dev Biol 54 2010 303 312
7. S. Muttukrishna, M. Swer, and S. Suri Soluble Flt-1 and PlGF: new markers of early pregnancy loss? PLoS One 6 2011 e18041
8. I.M. Ebisch, C.M. Thomas, A.M. Wetzels, W.N. Willemsen, F.C. Sweep, and R.P. Steegers-Theunissen Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility Fertil Steril 90 2008 2340 2350
9. M.S. Pepper, N. Ferrara, L. Orci, and R. Montesano Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells Biochem Biophys Res Commun 181 1991 902 906
10. E.K. Kruithof, M.S. Baker, and C.L. Bunn Biological and clinical aspects of plasminogen activator inhibitor type 2 Blood 86 1995 4007 4024
11. S. Timmermans, V.W. Jaddoe, and L.M. Silva Folic acid is positively associated with uteroplacental vascular resistance: the Generation R study Nutr Metab Cardiovasc Dis 21 2011 54 61
12. S.N. Doshi, I.F. McDowell, and S.J. Moat Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering Circulation 105 2002 22 26
13. R.P. Steegers-Theunissen, and E.A. Steegers Nutrient-gene interactions in early pregnancy: a vascular hypothesis Eur J Obstet Gynecol Reprod Biol 106 2003 115 117
14. P.J. Williams, J.N. Bulmer, B.A. Innes, and F. Broughton Pipkin Possible roles for folic acid in the regulation of trophoblast invasion and placental development in normal early human pregnancy Biol Reprod 84 2011 1148 1153
15. V.W. Jaddoe, C.M. van Duijn, and O.H. Franco The Generation R study: design and cohort update 2012 Eur J Epidemiol 27 2012 739 756
16. V.W. Jaddoe, R. Bakker, and C.M. van Duijn The Generation R study biobank: a resource for epidemiological studies in children and their parents Eur J Epidemiol 22 2007 917 923
17. M. Coolman, S. Timmermans, and C.J. de Groot Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes Obstet Gynecol 119 2012 1190 1200
18. N. Bergen, V. Jaddoe, and S. Timmermans Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R study BJOG 119 2012 739 751
19. B.O. Verburg, E.A. Steegers, and M. De Ridder New charts for ultrasound dating of pregnancy and assessment of fetal growth: longitudinal data from a population-based cohort study Ultrasound Obstet Gynecol 31 2008 388 396
20. B.O. Verburg, P.G. Mulder, A. Hofman, V.W. Jaddoe, J.C. Witteman, and E.A. Steegers Intra- and interobserver reproducibility study of early fetal growth parameters Prenat Diagn 28 2008 323 331
21. D.O. Mook-Kanamori, E.A. Steegers, P.H. Eilers, H. Raat, A. Hofman, and V.W. Jaddoe Risk factors and outcomes associated with first-trimester fetal growth restriction JAMA 303 2010 527 534
22. MA. Schroeder Diagnosing and dealing with multicollinearity West J Nurs Res 12 1990 175 184 discussion 184-7.
23. R.M. O'Brian A caution regarding rules of thumb for variance inflation factors Quality & Quantity 41 2007 673 690
24. D.B. Rubin, and N. Schenker Multiple imputation in health-care databases: an overview and some applications Stat Med 10 1991 585 598
25. G.C. Smith, and H. Wear The perinatal implications of angiogenic factors Curr Opin Obstet Gynecol 21 2009 111 116
26. R. Romero, J.K. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 2008 9 23
27. M. Jacobs, N. Nassar, C.L. Roberts, R. Hadfield, J.M. Morris, and A.W. Ashton Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review Reprod Biol Endocrinol 9 2011 77
28. G.C. Smith, J.A. Crossley, and D.A. Aitken Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth Obstet Gynecol 109 2007 1316 1324
29. T. Kasdaglis, G. Aberdeen, and O. Turan Placental growth factor in the first trimester: relationship with maternal factors and placental Doppler studies Ultrasound Obstet Gynecol 35 2010 280 285
30. C. Bottomley, and T. Bourne Dating and growth in the first trimester Best Pract Res Clin Obstet Gynaecol 23 2009 439 452
31. G.C. Smith First trimester origins of fetal growth impairment Semin Perinatol 28 2004 41 50
32. M. Coolman, C.J. de Groot, and E.A. Steegers Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy Eur J Obstet Gynecol Reprod Biol 128 2006 22 28
33. A. Ahmed, C. Dunk, S. Ahmad, and A. Khaliq Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) and soluble Flt-1 by oxygen-a review Placenta 21 Suppl 2000 S16 S24
34. B.O. Asvold, L.J. Vatten, P.R. Romundstad, P.A. Jenum, S.A. Karumanchi, and A. Eskild Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction Am J Epidemiol 173 2011 630 639
35. J. Reinartz, B. Schaefer, M.J. Bechtel, and M.D. Kramer Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator Exp Cell Res 223 1996 91 101
36. G.E. Hofmann, I. Glatstein, F. Schatz, D. Heller, and L. Deligdisch Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites Am J Obstet Gynecol 170 1994 671 676
37. J.L. Dickinson, E.J. Bates, A. Ferrante, and T.M. Antalis Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis: evidence for an alternate biological function J Biol Chem 270 1995 27894 27904
38. F. Vesce, C. Scapoli, G. Giovannini, A. Piffanelli, A. Geurts-Moespot, and F.C. Sweep Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies Obstet Gynecol 97 2001 404 408
39. R.P. Steegers-Theunissen, N.C. Wathen, T.K. Eskes, B. van Raaij-Selten, and T. Chard Maternal and fetal levels of methionine and homocysteine in early human pregnancy Br J Obstet Gynaecol 104 1997 20 24
40. R.P. Steegers-Theunissen, S.C. Smith, E.A. Steegers, L.J. Guilbert, and P.N. Baker Folate affects apoptosis in human trophoblastic cells BJOG 107 2000 1513 1515
41. S.N. Doshi, I.F. McDowell, and S.J. Moat Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol 21 2001 1196 1202
42. Y. Liu, E.B. Gold, B.L. Lasley, and W.O. Johnson Factors affecting menstrual cycle characteristics Am J Epidemiol 160 2004 131 140
43. R.H. Van Oppenraaij, A.H. Koning, and B.A. Lisman Vasculogenesis and angiogenesis in the first trimester human placenta: an innovative 3D study using an immersive virtual reality system Placenta 30 2009 220 222
44. C.M. Verwoerd-Dikkeboom, A.H. Koning, P.J. van der Spek, N. Exalto, and E.A. Steegers Embryonic staging using a 3D virtual reality system Hum Reprod 23 2008 1479 1484